131 related articles for article (PubMed ID: 12358939)
1. Serum levels of VEGF do not correlate with the severity of multiple myeloma.
Jakob C; Zavrski I; Heider U; Langelotz C; Eucker J; Possinger K; Sezer O
Br J Haematol; 2002 Oct; 119(1):276; author reply 276-7. PubMed ID: 12358939
[No Abstract] [Full Text] [Related]
2. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
3. Circulating hepatocyte growth factor levels in multiple myeloma.
Jakob C; Fleissner C; Zavrski I; Heider U; Possinger K; Sezer O
Br J Haematol; 2003 May; 121(3):532. PubMed ID: 12716383
[No Abstract] [Full Text] [Related]
4. Prognostic value of VEGF levels for ovarian hyperstimulation.
Bussen S; Dietl J
Fertil Steril; 2003 Sep; 80(3):681-2; author reply 682. PubMed ID: 12969739
[No Abstract] [Full Text] [Related]
5. Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF.
Pittini V; Teti D; Arrigo C; Aloi G; Righi M
Br J Haematol; 2002 Oct; 119(1):275. PubMed ID: 12358938
[No Abstract] [Full Text] [Related]
6. Correspondence re: K. Neben et al., high plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7: 2675-2681, 2001.
Go RS; Horstman AL
Clin Cancer Res; 2002 Aug; 8(8):2750; author reply 2751. PubMed ID: 12171909
[No Abstract] [Full Text] [Related]
7. Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera.
Murphy P; Ahmed N; Hassan HT
Leuk Res; 2002 Nov; 26(11):1007-1010. PubMed ID: 12363469
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe night time hypoxia.
Kähler CM; Wechselberger J; Molnar C; Prior C
Am J Respir Crit Care Med; 2003 Jan; 167(1):92-3; author reply 93. PubMed ID: 12502484
[No Abstract] [Full Text] [Related]
9. Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis.
Karayiannakis AJ; Bolanaki H; Syrigos KN; Asimakopoulos B; Polychronidis A; Anagnostoulis S; Simopoulos C
Cancer Lett; 2003 May; 194(1):119-24. PubMed ID: 12706865
[TBL] [Abstract][Full Text] [Related]
10. The importance of the VEGF-load in platelets in cancer patients.
Salgado R; Benoy I; van Marck E; Vermeulen P; Dirix L
Ann Oncol; 2002 Oct; 13(10):1689-90. PubMed ID: 12377663
[No Abstract] [Full Text] [Related]
11. Elevated serum vascular endothelial growth factor levels in patients with polycythemia vera and thrombotic complications.
Cacciola RR; Di Francesco E; Giustolisi R; Cacciola E
Haematologica; 2002 Jul; 87(7):774-5. PubMed ID: 12091131
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma.
Iwasaki T; Hamano T; Ogata A; Hashimoto N; Kitano M; Kakishita E
Br J Haematol; 2002 Mar; 116(4):796-802. PubMed ID: 11886383
[TBL] [Abstract][Full Text] [Related]
13. [Determination of vascular endothelial growth factor (VEGF) concentration in serum of patients with colorectal carcinoma].
Broll R; Erdmann H; Windhövel U; Duchrow M; Strik MW
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):315-8. PubMed ID: 14518267
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of vascular endothelial growth factor in advanced non-small cell lung cancer.
Trapé J; Buxó J; de Olaguer JP
Clin Chem; 2003 Mar; 49(3):523-5. PubMed ID: 12600977
[No Abstract] [Full Text] [Related]
15. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor in yersiniosis. A study on 157 military recruits.
Saebo A; Lassen J
Adv Exp Med Biol; 2003; 529():455-7. PubMed ID: 12756808
[No Abstract] [Full Text] [Related]
17. In vivo platelet activation is associated with increased plasma levels of vascular endothelial growth factor.
Martini F; Riondino S; Basili S; Bertazzoni G; Ferroni P
J Thromb Haemost; 2003 Apr; 1(4):853-4. PubMed ID: 12871428
[No Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor in monitoring therapy of hepatic haemangioendothelioma.
Szymik-Kantorowicz S; Partyka L; Dembinska-Kiec A; Zdzienicka A
Med Pediatr Oncol; 2003 Mar; 40(3):196-7. PubMed ID: 12518353
[No Abstract] [Full Text] [Related]
19. Serum concentrations of vascular endothelial growth factor in angiosarcomas with and without p53 gene mutation.
Amo Y; Masuzawa M; Hamada Y; Katsuoka K
Acta Derm Venereol; 2002; 82(5):373-4. PubMed ID: 12430738
[No Abstract] [Full Text] [Related]
20. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.
Heeschen C; Dimmeler S; Hamm CW; Boersma E; Zeiher AM; Simoons ML;
Circulation; 2003 Feb; 107(4):524-30. PubMed ID: 12566361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
